The founder of Johnson Products Co., as he insists in his new memoir, “Afro Sheen: How I Revolutionized an Industry with the ...
Healthcare conglomerate Johnson & Johnson kicks off its bankruptcy plan confirmation Tuesday, in its third attempt to resolve ...
The 49-year-old legend scored a third-place finish in the Great American Race, his best showing since winning for the second ...
Medtech giants are doubling down on robotic surgery systems as hospitals see fewer complications and shorter stays.
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk ...
In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), with a price ...
In a report released today, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a price ...
Education is a big part of Black History Month, and one Johnson County family has a history of fighting for education for the ...
Shah now anticipates that the company will post earnings per share of $2.60 for the quarter, down from their previous forecast of $2.63. The consensus estimate for Johnson & Johnson’s current ...
Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or ...
Check Out Our Latest Report on Johnson & Johnson Johnson & Johnson Stock Down 0.7 % NYSE JNJ opened at $156.20 on Friday. The company has a quick ratio of 0.79, a current ratio of 1.03 and a debt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results